Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.
Sitbon A, Hauw-Berlemont C, Mebarki M, Heming N, Mayaux J, Diehl JL, Demoule A, Annane D, Marois C, Demeret S, Weiss E, Voiriot G, Fartoukh M, Constantin JM, Mégarbane B, Plantefève G, Boucher-Pillet H, Churlaud G, Cras A, Maheux C, Pezzana C, Diallo MH, Lebbah S, Ropers J, Salem JE, Straus C, Menasché P, Larghero J, Monsel A; APHP STROMA–CoV‐2 Collaborative Research Group.
Sitbon A, et al. Among authors: straus c.
Stem Cell Res Ther. 2024 Apr 19;15(1):109. doi: 10.1186/s13287-024-03729-w.
Stem Cell Res Ther. 2024.
PMID: 38637891
Free PMC article.
Clinical Trial.